Company

GV20 Therapeutics

Biotechnology Research Cambridge, Massachusetts, United States 22 employees

Employees: 22
Contacts: 3
Emails: 3
Phones: 2

gv20tx.com LinkedIn

GV20 Therapeutics Overview

Headquarters: Cambridge, Massachusetts, United States
Website: gv20tx.com
Industry: Biotechnology Research
Employees: 22
Founded: 2016
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

AI Antibody Immunotherapy Genomics

About GV20 Therapeutics

GV20 Therapeutics (https://gv20tx.com) was incorporated in 2016 with sites in Cambridge, USA, and Shanghai, China. The company utilizes high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets, and discover and develop effective antibody drugs in cancer. GV20's proprietary antibody drug discovery engine has helped establish a solid portfolio of immuno-oncology antibody drug candidates for cancer treatment.

GV20 Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

GV20 Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Xihao Hu	CIO of Gv20 Therapeutics	Boston, Massachusetts, United States	Email
Xiaole Shirley Liu	Co-founder & CEO, Gv20therapeutics	Cambridge, Massachusetts, United States	Email Phone
Ann Yin		Greater Boston, United States	View
Xingfeng Bao	VP, Head of Biology	Cambridge, Massachusetts, United States	Email Phone